Response to Comments: Epidural Steroid Injections for Pain Management

This document is a response-to-comments article for LCD L38994, which was retitled to 'Epidural Steroid Injections for Pain Management' and developed collaboratively by multiple Medicare contractors. The LCD comment period ran from 2021-05-20 to 2021-07-03, the notice period began on 2021-10-21, and the LCD became effective on 2021-12-05. No clinical coverage criteria, indications, limitations, or claim documentation requirements are provided in this response document; refer to LCD L38994 for the detailed coverage policy.

"This article provides responses to comments for LCD L38994 (renamed to 'Epidural Steroid Injections for Pain Management'); the comment period was 2021-05-20 to 2021-07-03, the notice period begins ..."

Sign up to see full coverage criteria, indications, and limitations.